Skip to main content

Nutex Health Inc.

NUTX
Exchange
Nasdaq
Industry
Services-Business Services, NEC
SEC CIK
0001479681

In the last 90 days, Nutex Health Inc. insiders filed 0 open-market purchases and 1 sale; 154 institutions reported holding it in 13F filings for Q2 2026, worth $501.9M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 9, 2026
$1.33B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $43.5K in total
1
13F holdersQ2 2026, +25 vs. previous quarter
154
13F valueReported value at the end of Q2 2026
$501.9M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$875.3M
+82.4% year over year
Net income, FY2025
$70.8M
+35.9% year over year
Free cash flow, FY2025
$245.6M
+1,077.9% year over year
Revenue, Q3 FY2026
$217.6M
−18.7% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 15, 2026.

Short interest
1.24M
Shares sold short
Change
−13.4K
−1.1% vs. previous
Days to cover
7.56
At average daily volume

Superinvestors holding NUTX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding NUTX at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Nutex Health Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2026 (view filing)2:51 PM ETSep 18Same daySaunders Scott JDirectorSSale−203$214.25−$43.5K−33.7%400 after
Mar 23, 2026 (view filing)Mar 194 daysHosseinion WarrenPresidentPPurchase+252$94.07+$23.7K+3.4%7.76K after
Mar 23, 2026 (view filing)Mar 203 daysJaumot Frank EDirectorPPurchase+150$93.56+$14.0KNew position150 after
Mar 18, 2026 (view filing)Mar 171 daySpears KelvinDirectorPPurchase+10$94.46+$944.60.0%32.1K after
Mar 16, 2026 (view filing)Mar 133 daysMontgomery Pamela W.Chief Legal Officer-HealthcarePPurchase+79$88.87+$7.02K+2.9%2.76K after
Nov 28, 2025 (view filing)Nov 253 daysBates Jon ChristianChief Financial OfficerPPurchase+750$136.71+$102.5K+15.3%5.64K after
Apr 14, 2025 (view filing)Apr 86 daysLateBates Jon ChristianChief Financial OfficerPPurchase+1.00K$81.81+$81.8K+25.7%4.89K after
Aug 26, 2024 (view filing)Aug 224 daysBates Jon ChristianChief Financial OfficerPPurchase+1.35K$21.46+$29.0K+145.6%2.28K after
Aug 21, 2024 (view filing)Aug 19-202 daysDeTillio JoshuaChief Operating OfficerPPurchase+1.88K$17.71+$33.2K+63.9%4.81K after2 lots
Jun 13, 2024 (view filing)Jun 121 dayDeTillio JoshuaChief Operating OfficerPPurchase+20.0K$0.54+$10.8K+214.3%29.3K after

Top 10 13F holders, Q2 2026

See all 154 holders

The largest institutional positions in Nutex Health Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding NUTX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Pertento Partners LLP451,310$77.1M5.54%+77,340+20.7%Added
BlackRock, Inc.407,349$69.6M0.00%+27,994+7.4%Added
American Century Companies Inc237,414$40.6M0.02%+33,964+16.7%Added
Vanguard Capital Management LLC215,919$36.9M0.00%−3,212−1.5%Reduced
Geode Capital Management, LLC132,049$22.6M0.00%+9,936+8.1%Added
State Street Corp130,836$22.4M0.00%+7,659+6.2%Added
D. E. Shaw & Co., Inc.97,454$16.7M0.01%+97,454New
UBS Group AG77,912$13.3M0.00%+8,342+12.0%Added
Winmill & Co. Inc65,350$11.2M2.47%00.0%Unchanged
Colony Group, LLC60,881$10.4M0.01%+60,881New

Holders of 5% or more of NUTX

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nutex Health Inc..

Largest holders of NUTX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Topline Capital Management, LLC13G/A9.90%556.6K shares+4.80 ppfrom 5.10%Jul 16, 20252 filingsOct 29, 2025SEC
Pertento Partners LLP13G/A5.90%405.0K shares+0.70 ppfrom 5.20%Nov 7, 20254 filingsMay 7, 2026SEC
BlackRock, Inc.13G5.30%367.6K sharesNewApr 27, 20261 filingApr 27, 2026SEC